» Articles » PMID: 12562689

On Functional and Structural Heterogeneity of VIM-type Metallo-beta-lactamases

Overview
Date 2003 Feb 4
PMID 12562689
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

The VIM metallo-beta-lactamases are emerging resistance determinants, encoded by mobile genetic elements, that have recently been detected in multidrug-resistant nosocomial isolates of Pseudomonas aeruginosa and other Gram-negative pathogens. In this work a T7-based expression system for overproduction of the VIM-2 enzyme by Escherichia coli was developed, which yielded approximately 80 mg of protein per litre of culture. The enzyme was mostly released into the medium, from which it was recovered at >99% purity by an initial ammonium sulphate precipitation followed by two chromatography steps, with almost 80% efficiency. Determination of kinetic parameters of VIM-2 under the same experimental conditions previously used for VIM-1 (the first VIM-type enzyme detected in clinical isolates, which is 93% identical to VIM-2) revealed significant differences in K(m) values and/or turnover rates with several substrates, including penicillins, cephalosporins and carbapenems. Compared with VIM-1, VIM-2 is more susceptible to inactivation by chelators, indicating that the zinc ions of the latter are probably more loosely bound. These data indicated that at least some of the amino acid differences between the two proteins have functional significance. Molecular modelling of the two enzymes identified some amino acid substitutions, including those at positions 223, 224 and 228 (in the BBL numbering), that could be relevant to the changes in catalytic behaviour.

Citing Articles

An Investigation Into Carbapenem Resistance in Enterobacteriaceae Among Outpatients With Urinary Tract Infection in Southwestern Uganda.

Tuhamize B, Tusubira D, Masembe C, Bessong P, Bazira J Cureus. 2024; 16(10):e72387.

PMID: 39583468 PMC: 11586080. DOI: 10.7759/cureus.72387.


Structure-Based Optimization of 1,2,4-Triazole-3-Thione Derivatives: Improving Inhibition of NDM-/VIM-Type Metallo-β-Lactamases and Synergistic Activity on Resistant Bacteria.

Bersani M, Failla M, Vascon F, Gianquinto E, Bertarini L, Baroni M Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139809 PMC: 10747250. DOI: 10.3390/ph16121682.


Taxifolin as a Metallo-β-Lactamase Inhibitor in Combination with Augmentin against Verona Imipenemase 2 Expressing .

Benin B, Hillyer T, Crugnale A, Fulk A, Thomas C, Crowder M Microorganisms. 2023; 11(11).

PMID: 38004664 PMC: 10673258. DOI: 10.3390/microorganisms11112653.


Neutralizing Carbapenem Resistance by Co-Administering Meropenem with Novel β-Lactam-Metallo-β-Lactamase Inhibitors.

Reddy N, Girdhari L, Shungube M, Gouws A, Peters B, Rajbongshi K Antibiotics (Basel). 2023; 12(4).

PMID: 37106995 PMC: 10135050. DOI: 10.3390/antibiotics12040633.


Discovery and Optimization of a Novel Macrocyclic Amidinourea Series Active as Acidic Mammalian Chitinase Inhibitors.

Balestri L, Trivisani C, Orofino F, Fiorucci D, Truglio G, DAgostino I ACS Med Chem Lett. 2023; 14(4):417-424.

PMID: 37077400 PMC: 10107916. DOI: 10.1021/acsmedchemlett.2c00472.